Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Autori principali: Tangui Barré (Autore), Fabrice Carrat (Autore), Clémence Ramier (Autore), Hélène Fontaine (Autore), Vincent Di Beo (Autore), Morgane Bureau (Autore), Céline Dorival (Autore), Dominique Larrey (Autore), Elisabeth Delarocque-Astagneau (Autore), Philippe Mathurin (Autore), Fabienne Marcellin (Autore), Ventzislava Petrov-Sanchez (Autore), Carole Cagnot (Autore), Patrizia Carrieri (Autore), Stanislas Pol (Autore), Camelia Protopopescu (Autore), the ANRS/AFEF Hepather study group (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2022-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...